{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:15:05Z","timestamp":1781558105512,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Uterine fibroids are highly prevalent and often symptomatic, leading to abnormal uterine bleeding (AUB) and impaired quality of life. While hysteroscopic myomectomy (HSC) is the gold-standard treatment for submucosal fibroids, it is limited in addressing deeper lesions. Transcervical radiofrequency ablation (TFA) offers a minimally invasive alternative for intramural and transmural fibroids. This study evaluated the safety and effectiveness of combining TFA with HSC in a single session compared to HSC alone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study design<\/jats:title>\n            <jats:p>We conducted a retrospective multicenter analysis of 127 women with symptomatic fibroids and AUB. Patients underwent either combined TFA\u2009+\u2009HSC (n\u2009=\u200975) or HSC alone (n\u2009=\u200952). Outcomes included intraoperative bleeding, complications, and symptom improvement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The combined group treated a broader range of fibroid types (FIGO 0\u20136) and larger fibroids (mean size 2.86\u00a0cm vs. 2.23\u00a0cm; p\u2009=\u20090.0013). Intraoperative bleeding was significantly lower in the combined group (0% vs. 9.6%; p\u2009=\u20090.0102), with no increase in total complication rates (8% vs. 15%; p\u2009=\u20090.2512). Among patients with follow-up data, 85.1% reported symptom improvement after combined treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Combining TFA with hysteroscopic myomectomy is a safe and effective approach that expands the range of treatable fibroids, reduces intraoperative bleeding, and maintains high patient satisfaction. This integrated strategy offers advantages in tissue diagnosis, potential cost savings, and uterine preservation, making it a valuable addition to minimally invasive fibroid management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00404-025-08127-y","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T18:48:12Z","timestamp":1753210092000},"page":"1247-1252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combined transcervical radiofrequency ablation and hysteroscopic myomectomy: expanding treatment to diverse fibroid types"],"prefix":"10.1007","volume":"312","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2544-4770","authenticated-orcid":false,"given":"Elvin","family":"Piriyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Dieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Schiermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan Peter","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"R\u00f6mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"9252","key":"8127_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","volume":"357","author":"EA Stewart","year":"2001","unstructured":"Stewart EA (2001) Uterine fibroids. Lancet 357(9252):293\u2013298. https:\/\/doi.org\/10.1016\/S0140-6736(00)03622-9","journal-title":"Lancet"},{"issue":"14","key":"8127_CR2","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMra1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun SE (2013) Uterine fibroids. N Engl J Med 369(14):1344\u20131355. https:\/\/doi.org\/10.1056\/NEJMra1209993","journal-title":"N Engl J Med"},{"issue":"4","key":"8127_CR3","doi-asserted-by":"publisher","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","volume":"209","author":"BJ Borah","year":"2013","unstructured":"Borah BJ, Nicholson WK, Bradley L, Stewart EA (2013) The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol 209(4):319.e1-319.e20. https:\/\/doi.org\/10.1016\/j.ajog.2013.07.017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"8127_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.fertnstert.2007.06.044","volume":"88","author":"WH Parker","year":"2007","unstructured":"Parker WH (2007) Uterine myomas: management. Fertil Steril 88(2):255\u2013271. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.06.044","journal-title":"Fertil Steril"},{"issue":"6","key":"8127_CR5","first-page":"641","volume":"60","author":"V DaCosta","year":"2011","unstructured":"DaCosta V, Wynter S, Harriott J, Christie L, Berry E, Frederick-Johnston S, Frederick J (2011) Operative hysteroscopy in a Jamaican cohort. West Indian Med J 60(6):641\u2013646 (PMID: 22512221)","journal-title":"West Indian Med J"},{"key":"8127_CR6","volume-title":"Hysteroscopic guide for gynecologists","author":"T R\u00f6mer","year":"2008","unstructured":"R\u00f6mer T (2008) Hysteroscopic guide for gynecologists, 2nd edn. De Gruyter","edition":"2"},{"issue":"1","key":"8127_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00404-022-06516-1","volume":"306","author":"T R\u00f6mer","year":"2022","unstructured":"R\u00f6mer T, Bends R, Christoffel L, Felberbaum R, Hildebrandt T, Meinhold-Heerlein I, Mueller M, Oppelt P, Renner SP, Runnebaum IB, Schiermeier S, Piriyev E, Uhl B, Toub D (2022) The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countries. Arch Gynecol Obstet 306(1):1\u20136. https:\/\/doi.org\/10.1007\/s00404-022-06516-1","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"8127_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s13669-017-0194-2","volume":"6","author":"DB Toub","year":"2017","unstructured":"Toub DB (2017) A new paradigm for uterine fibroid treatment: transcervical, intrauterine sonography-guided radiofrequency ablation of uterine fibroids with the Sonata system. Curr Obstet Gynecol Rep 6(1):67\u201373. https:\/\/doi.org\/10.1007\/s13669-017-0194-2","journal-title":"Curr Obstet Gynecol Rep"},{"issue":"2","key":"8127_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/gyn.2021.0073","volume":"38","author":"K Roy","year":"2022","unstructured":"Roy K, Robinson JK (2022) Durable improvement in generic and fibroid-specific quality of life in women treated with transcervical fibroid ablation with the Sonata system after three years. J Gynecol Surg 38(2):143\u2013147. https:\/\/doi.org\/10.1089\/gyn.2021.0073","journal-title":"J Gynecol Surg"},{"issue":"2","key":"8127_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5114\/wiitm.2022.113565","volume":"17","author":"E Piriyev","year":"2022","unstructured":"Piriyev E, Schiermeier S, R\u00f6mer T (2022) Combined procedure of the transcervical radiofrequency ablation (TRFA) system and surgical hysteroscopy. Increased risk or safe procedure? Wideochir Inne Tech Maloinwazyjne 17(2):380\u2013384. https:\/\/doi.org\/10.5114\/wiitm.2022.113565","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"8127_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10397-006-0188-y","volume":"3","author":"D Yu","year":"2006","unstructured":"Yu D, Li TC, Xia E, Huang X, Zheng J (2006) A prospective randomized controlled trial on the effectiveness of routine Foley balloon tamponade on the reduction of bleeding after hysteroscopic resection of myoma. Gynecol Surg 3:93\u201396. https:\/\/doi.org\/10.1007\/s10397-006-0188-y","journal-title":"Gynecol Surg"},{"issue":"1","key":"8127_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ijgo.13638","volume":"155","author":"G Shifrin","year":"2021","unstructured":"Shifrin G, Engelhardt M, Gee P, Pschadka G (2021) Transcervical fibroid ablation with the Sonata\u2122 system for treatment of submucous and large uterine fibroids. Int J Gynaecol Obstet 155(1):79\u201385. https:\/\/doi.org\/10.1002\/ijgo.13638","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"8127_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10397-015-0915-3","volume":"13","author":"H Br\u00f6lmann","year":"2016","unstructured":"Br\u00f6lmann H, Bongers M, Garza-Leal JG, Gupta J, Veersema S, Quartero R, Toub D (2016) The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg 13(1):27\u201335. https:\/\/doi.org\/10.1007\/s10397-015-0915-3","journal-title":"Gynecol Surg"},{"issue":"5 Pt 1","key":"8127_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/s0029-7844(98)00558-4","volume":"93","author":"MH Emanuel","year":"1999","unstructured":"Emanuel MH, Wamsteker K, Hart AA, Metz G, Lammes FB (1999) Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol 93(5 Pt 1):743\u2013748. https:\/\/doi.org\/10.1016\/s0029-7844(98)00558-4","journal-title":"Obstet Gynecol"},{"issue":"3","key":"8127_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/gyn.2021.0136","volume":"38","author":"L Christoffel","year":"2022","unstructured":"Christoffel L, Bends R, Toub D, Schiermeier S, Pschadka G, Engelhardt M, Quinn S, Hartmann M, Habiba M, Felberbaum R, Br\u00f6ssner A, Schippert C, R\u00f6mer T (2022) Pregnancy outcomes after transcervical radiofrequency ablation of uterine fibroids with the Sonata system. J Gynecol Surg 38(3):207\u2013213. https:\/\/doi.org\/10.1089\/gyn.2021.0136","journal-title":"J Gynecol Surg"},{"issue":"10","key":"8127_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13102892","volume":"13","author":"L Hansen-Lindner","year":"2024","unstructured":"Hansen-Lindner L, Schmid-Lossberg J, Toub D (2024) Transcervical fibroid ablation (TFA): update on pregnancy outcomes. J Clin Med 13(10):2892. https:\/\/doi.org\/10.3390\/jcm13102892","journal-title":"J Clin Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08127-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08127-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08127-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:08:38Z","timestamp":1757462918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08127-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["8127"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08127-y","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"E.P. and A.D. have no conflicts of interest in this work. S.S., S.R. and T.R. are consultants for the Sonata System. The authors report no other conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"According to 15\u00a7 of the professional code of the North Rhine Medical Association, neither advice nor an ethics vote is necessary for a retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}